Verquvo 10 mg film-coated tablets

DRUG2 trials

Sponsors

Amsterdam UMC, Rigshospitalet

Conditions

Heart failure with reduced ejection fraction (HFrEF)Unequivocal epicardial and/or microvascular vasospastic angina

Phase 2

Vericiguat in Vasospastic Angina (ViVA)

RecruitingCTIS2022-502998-42-00

Amsterdam UMCUnequivocal epicardial and/or microvascular vasospastic angina

Start: 2025-02-10Target: 55Updated: 2026-01-21

Phase 4

ARETHA: cARdiomems vEriciguaT Heart fAilure (A double-blind randomized placebo-controlled trial of vericiguat in heart failure patients with CardioMEMS™ HF System)

RecruitingCTIS2024-514111-10-00

RigshospitaletHeart failure with reduced ejection fraction (HFrEF)

Start: 2024-12-06Target: 17Updated: 2025-04-16